Live Breaking News & Updates on Qardio

Stay informed with the latest breaking news from Qardio on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Qardio and stay connected to the pulse of your community

Early Black Friday Sale on Top Blood Pressure Monitors

Add a blood pressure monitor to your smart home and your health regimen with these early Black Friday deals.

Qardio , Black-friday , Omron-connect , Qardioarm-blood-pressure , Health-track , Smart-home , Best-buy-2023 , Best-buy-deals , Black-friday-2023 , Black-friday-deals , Blood-pressure-monitor-deals

Qardio Welcomes New Board Members and Chairman as the Company Continues to Launch Disruptive Technology

/PRNewswire/ -- Qardio, a leader in connected care with predictive insight for a changing world, is proud to welcome new members to its board: new Chairman...

Mike-alvarez , Prnewswire-qardio , David-steinhaus , Leopoldo-zambeletti , Alpha-therapeutic-corporation , Grifols-inc , Jp-morgan , Medtronic , Chairman-gregory-rich , Gregory-rich , Vice-president , General-manager

Qardio, Inc.: Qardio Names Mike Alvarez as President and Chief Executive Officer

Former Medtronic Executive Brings Significant Experience in Cardiac and Remote Patient Monitoring to Help Deliver Qardio's Mission to Transform Cardiac and Chronic Care Qardio, Inc. ("Qardio" or

Kostenloser-wertpapierhandel , Luca-tassan , Qardio-inc , Services-operating-unit-at-medtronic , Qardio-or-company , Medtronic , Remote-patient-monitoring , Help-deliver-qardio , Transform-cardiac , Mike-alvarez , Chief-executive-officer , Vice-president

Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG

Share this article
SAN FRANCISCO, March 11, 2021 /PRNewswire/ --
Qardio, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510k clearance for its QardioCore ambulatory ECG device. QardioCore will initially be marketed for holter monitoring applications, for use with QardioMD, Qardio's cloud-based remote patient monitoring solution.
QardioCore extends Qardio's remote patient monitoring platform from primary care and hypertension monitoring to acute care and cardiology, in a single, intuitive platform.
The QardioCore ambulatory ECG from Qardio
QardioCore extends Qardio's RPM platform from primary care and hypertension to acute care and cardiology
QardioCore requires no special skin preparation, gels, adhesives, or patches. It can easily be self-fit, removed, and re-fit by the patient. Ideal for remote deployment, QardioCore does not require an in-clinic fitting. Qardio intends to launch the service in the U.S. in mid-2021.

Rosario-iannella , Qardio-inc , Qardio-app , Qardio , Inc , இன்க் ,